Literature DB >> 3538187

Cardiovascular effects of adenosine in man; possible clinical implications.

A Sollevi.   

Abstract

The results summarized above indicate that adenosine is a physiologically relevant modulator of the cardiovascular system in man. The levels of adenosine are low during resting conditions, but may increase during conditions of oxygen and/or substrate deficiency. Already the basal concentration seems to be sufficient to affect regional flow in vital organs such as the heart. Several drugs may act by increasing the levels of adenosine or by influencing its receptors. In addition, adenosine may be used in many clinical situations as a vasodilator, antiaggregatory compound as well as an antiarrythmic agent. Its effect is easy to control due to the extremely short plasma half-life. The dose range for the clinical effects are summarized in Table 6. Both the physiological and pharmacological aspect of adenosine are subject to intense study in several laboratories.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3538187     DOI: 10.1016/0301-0082(86)90005-5

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  36 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Adenosine deaminase and adenosine uptake inhibitions facilitate ventilation in rats.

Authors:  E C Monteiro; J A Ribeiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

3.  Vasomotor coronary oscillations: a model to evaluate autoregulation.

Authors:  A Y Wong; G A Klassen
Journal:  Basic Res Cardiol       Date:  1991 Sep-Oct       Impact factor: 17.165

4.  Evidence for the presence of A1 and A2 adenosine receptors in the ventral aorta of the dogfish shark, Squalus acanthias.

Authors:  D H Evans
Journal:  J Comp Physiol B       Date:  1992       Impact factor: 2.200

Review 5.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

6.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

7.  Effect of infused adenosine on cardiac output and systemic resistance in normal subjects.

Authors:  A Bush; C M Busst; B Clarke; P J Barnes
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

8.  Adenosine and 2-phenylaminoadenosine (CV-1808) inhibit human neutrophil bactericidal function.

Authors:  G E Hardart; G W Sullivan; H T Carper; G L Mandell
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  Uptake of purines in Plasmodium falciparum-infected human erythrocytes is mostly mediated by the human equilibrative nucleoside transporter and the human facilitative nucleobase transporter.

Authors:  Neils B Quashie; Lisa C Ranford-Cartwright; Harry P de Koning
Journal:  Malar J       Date:  2010-01-29       Impact factor: 2.979

10.  Comparison of the haemodynamic effects of adenosine monophosphate with sodium nitroprusside in a canine model of acute global left ventricular dysfunction.

Authors:  B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.